Clinical Trials · NCT06635629
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Enrollment
- 140
- Start date
- Dec 2024
- Locations
- 1 site, United States
- Primary endpoint
- ACTH and cortisol responses